Related Experiment Video
Updated: Aug 25, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Abstract:
The burden of HIV on society in the developing world and the price for treatment is enormous. The recent agreement between the Clinton Foundation and generic pharmaceutical companies is a major step forward. Also the cost-effectiveness is superior to treatment of for example hypercholesterolaemia. However, there are other prices to be paid, since drugs may induce unfavourable and unwanted side effects. For the future the challenge remains to keep all prices for HIV treatment as low as possible. Only an affordable and harmless HIV treatment might bring the progress of the HIV pandemic to a halt.
Related Concept Videos
Retrovirus Life Cycles
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Inhibitors of Virion Maturation and Assembly

